Cargando…

Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis

IMPORTANCE: Standard therapy for locally advanced rectal cancer includes concurrent chemoradiotherapy followed by surgery and adjuvant chemotherapy (CRT plus A). An alternative strategy known as total neoadjuvant therapy (TNT) involves administration of CRT plus neoadjuvant chemotherapy before surge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasi, Anup, Abbasi, Saqib, Handa, Shivani, Al-Rajabi, Raed, Saeed, Anwaar, Baranda, Joaquina, Sun, Weijing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745099/ https://www.ncbi.nlm.nih.gov/pubmed/33326026 http://dx.doi.org/10.1001/jamanetworkopen.2020.30097

Ejemplares similares

Immune Checkpoint Inhibitors versus VEGF Targeted Therapy as Second Line Regimen in Advanced Hepatocellular Carcinoma (HCC): A Retrospective Study
por: Saeed, Anwaar, et al.
Publicado: (2020)

Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapy
por: Hentzen, Stijn, et al.
Publicado: (2023)

Association of Neutrophil, Platelet, and Lymphocyte Ratios with the Prognosis in Unresectable and Metastatic Pancreatic Cancer
por: Allen, Jessica, et al.
Publicado: (2020)

Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review
por: Mohyuddin, Ghulam Rehman, et al.
Publicado: (2020)

Clinical Outcome of Ampullary Carcinoma: Single Cancer Center Experience
por: Al-Jumayli, Mohammed, et al.
Publicado: (2019)

A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction (GEJ), and stomach adenocarcinoma
por: Sun, Weijing, et al.
Publicado: (2023)

Update on the Role of Poly (ADP-Ribose) Polymerase Inhibitors in the DNA Repair-Deficient Pancreatic Cancers: A Narrative Review
por: Kasi, Anup, et al.
Publicado: (2020)

Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results
por: Saeed, Anwaar, et al.
Publicado: (2023)

Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure
por: Tuta, Mojca, et al.
Publicado: (2021)

Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal Cancer
por: Chin, Re-I, et al.
Publicado: (2022)

Impact of Total Neoadjuvant Therapy vs. Standard Chemoradiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis of Randomized Trials
por: Riesco-Martinez, Maria C., et al.
Publicado: (2020)

Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients
por: Freed, Ian M., et al.
Publicado: (2023)

Total neoadjuvant therapy for rectal cancer: evidence and challenge
por: Lee, Suk-Hwan
Publicado: (2023)

A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait Management
por: Weiser, Martin R., et al.
Publicado: (2022)

Debating Pros and Cons of Total Neoadjuvant Therapy in Rectal Cancer
por: Sclafani, Francesco, et al.
Publicado: (2021)

Total neoadjuvant therapy for rectal cancer: a guide for surgeons
por: Johnson, Garrett G.R.J., et al.
Publicado: (2023)

Total neoadjuvant therapy or standard chemoradiotherapy for locally advanced rectal cancer: A systematic review and meta-analysis
por: Ma, Zhou, et al.
Publicado: (2022)

Cost-effectiveness of Short-Course Radiation Therapy vs Long-Course Chemoradiation for Locally Advanced Rectal Cancer
por: Raldow, Ann C., et al.
Publicado: (2019)

Total neoadjuvant therapy versus standard therapy in locally advanced rectal cancer: A systematic review and meta-analysis of 15 trials
por: Zhang, Xiping, et al.
Publicado: (2022)

Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer
por: Zhu, Shaoyu, et al.
Publicado: (2019)

MRI VS. FDG-PET for diagnosis of response to neoadjuvant therapy in patients with locally advanced rectal cancer
por: Gao, Peng Fei, et al.
Publicado: (2023)

Total neoadjuvant therapy in locally advanced rectal cancer: Role of systemic chemotherapy
por: Yoo, Ri Na, et al.
Publicado: (2019)

The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation
por: IV, Arthur Affleck, et al.
Publicado: (2022)

Association Between Baseline Diastolic Blood Pressure and the Efficacy of Intensive vs Standard Blood Pressure–Lowering Therapy
por: Foy, Andrew J., et al.
Publicado: (2021)

Effect of Cold Atmospheric Plasma Therapy vs Standard Therapy Placebo on Wound Healing in Patients With Diabetic Foot Ulcers: A Randomized Clinical Trial
por: Stratmann, Bernd, et al.
Publicado: (2020)

Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview
por: Guida, Andrea M., et al.
Publicado: (2022)

How We Treat Localized Rectal Cancer—An Institutional Paradigm for Total Neoadjuvant Therapy
por: Roeder, Falk, et al.
Publicado: (2022)

Total neoadjuvant therapy in rectal cancer: a network meta-analysis of randomized trials
por: Sychev, Sergey, et al.
Publicado: (2023)

Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer
por: Ferrari, Linda, et al.
Publicado: (2015)

Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor Biopsies
por: Jo, Peter, et al.
Publicado: (2016)

Rectal cancer sub-clones respond differentially to neoadjuvant therapy()
por: Frydrych, Lynn M, et al.
Publicado: (2019)

Outcomes in Patients Treated by Laparoscopic Resection of Rectal Carcinoma After Neoadjuvant Therapy for Rectal Cancer
por: Rezvani, Masoud, et al.
Publicado: (2007)

Transcriptomic Analyses of Pretreatment Tumor Biopsy Samples, Response to Neoadjuvant Chemoradiotherapy, and Survival in Patients With Advanced Rectal Cancer
por: Akiyoshi, Takashi, et al.
Publicado: (2023)

Effect of Long-term Nicotine Replacement Therapy vs Standard Smoking Cessation for Smokers With Chronic Lung Disease: A Randomized Clinical Trial
por: Ellerbeck, Edward F., et al.
Publicado: (2018)

Biomarker expression in rectal cancer tissue before and after neoadjuvant therapy
por: Boogerd, Leonora SF, et al.
Publicado: (2018)

FGF8 induces therapy resistance in neoadjuvantly radiated rectal cancer
por: Harpain, Felix, et al.
Publicado: (2018)

Density and distribution of lymphocytes in pretherapeutic rectal cancer and response to neoadjuvant therapy
por: Lai, Sicong, et al.
Publicado: (2020)

Rectal Cancer Tissue Lipidome Differs According to Response to Neoadjuvant Therapy
por: Sánchez-Vinces, Salvador, et al.
Publicado: (2023)

Comparative Effectiveness of Digital Cognitive Behavioral Therapy vs Medication Therapy Among Patients With Insomnia
por: Lu, Menglin, et al.
Publicado: (2023)

Does the Gain of Total Neoadjuvant Therapy Outweigh the Harm in Rectal Cancer? Importance of the ATRESS (neoAdjuvant Therapy-RElated Shortening of Survival) Phenomenon: A Systematic Review
por: Socha, Joanna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5hlioe6efcso9mdl4tlsks4l08